Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1623

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters

Filter Results:

Show Only CME Accredited Sessions

  • +

    P09 - Health Services Research/Health Economics - Real World Outcomes

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P09.01 - Different Administration Routes of Endostar Combined with Chemotherapy in the Treatment of Advanced NSCLC, a Real World Study

      00:00 - 00:00  |  Presenting Author(s): Wei Jiang

      • Abstract

      Loading...

    • +

      P09.02 - Impact of COVID-19 in Portuguese Lung Cancer Patients’ Treatment: Portuguese Lung Cancer Study Group Survey

      00:00 - 00:00  |  Presenting Author(s): Fernanda Estevinho

      • Abstract

      Loading...

    • +

      P09.03 - Thyroid Dysfunction in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors (ICI): Outcomes in a Multiethnic Urban Cohort.

      00:00 - 00:00  |  Presenting Author(s): Angelica D'Aiello

      • Abstract

      Loading...

    • +

      P09.04 - Changing Survival and Treatment Patterns in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) in Alberta, Canada

      00:00 - 00:00  |  Presenting Author(s): Matthew Anaka

      • Abstract

      Loading...

    • +

      P09.05 - Surveillance, Patterns of Recurrence and Survivorship in Early Stage Lung Cancer Patients Following Curative Intent Treatment

      00:00 - 00:00  |  Presenting Author(s): Sobasha Perera

      • Abstract

      Loading...

    • +

      P09.06 - CNS Metastasis Negatively Impact Overall Survival of Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immune Checkpoint Inhibitors. 

      00:00 - 00:00  |  Presenting Author(s): Camila Iasmim de Andrade Souza

      • Abstract

      Loading...

    • +

      P09.07 - Oncologists Practices and Perceptions on Management of Brain Metastases from Non-Small Cell Lung Cancers-: A Nationally Representative Survey

      00:00 - 00:00  |  Presenting Author(s): Srinivas Chilukuri

      • Abstract

      Loading...

    • +

      P09.08 - Age-Related Outcomes of First-Line Pembrolizumab in a Real-World Non-Small-Cell Lung Cancer (NSCLC) Cohort

      00:00 - 00:00  |  Presenting Author(s): Heidi A.I. Grosjean

      • Abstract

      Loading...

    • +

      P09.09 - Overall Survival in Elderly Metastatic Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

      00:00 - 00:00  |  Presenting Author(s): Maria Fernanda Simões

      • Abstract

      Loading...

    • +

      P09.10 - Nationwide Effect of High Procedure Volume in Lung Cancer Surgery on In-House Mortality in Germany

      00:00 - 00:00  |  Presenting Author(s): Philip Baum

      • Abstract

      Loading...

    • +

      P09.11 - Nutritional Risk Status Predicts Overall Survival of Mexican Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).

      00:00 - 00:00  |  Presenting Author(s): Saul Campos-Gomez

      • Abstract

      Loading...

    • +

      P09.12 - SARS- CoV2 Impact in a Spanish Lung Cancer Cohort?

      00:00 - 00:00  |  Presenting Author(s): Virginia Calvo

      • Abstract

      Loading...

    • +

      P09.13 - Bone Metastases and Overall Survival in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Pembrolizumab

      00:00 - 00:00  |  Presenting Author(s): Parthib Das

      • Abstract

      Loading...

    • +

      P09.14 - Predictive Analytics in Real-World Data from Peru: The New Models for Personalized Oncology.

      00:00 - 00:00  |  Presenting Author(s): Luis Pino

      • Abstract

      Loading...

    • +

      P09.15 - Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19

      00:00 - 00:00  |  Presenting Author(s): Laia Fernández-Mañas

      • Abstract

      Loading...

    • +

      P09.16 - Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC). Real-Life Experience from Castile and Leon

      00:00 - 00:00  |  Presenting Author(s): Soledad Medina Valdivieso

      • Abstract

      Loading...

    • +

      P09.17 - Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung)

      00:00 - 00:00  |  Presenting Author(s): Kathryn Banfill

      • Abstract

      Loading...

    • +

      P09.18 - COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)

      00:00 - 00:00  |  Presenting Author(s): Umit Tapan

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      P09.19 - Health Disparities Characteristics in Cancer Survivorships among Sexual Minorities in the US - A Cross-Sectional Study Using BRFSS 2018 Data

      00:00 - 00:00  |  Presenting Author(s): Yannan Li

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      P09.20 - Impact of Antibiotics During Immune Checkpoint Inhibitor (ICI) Therapy for Non-Small Cell Lung Cancer: A Real-World Analysis

      00:00 - 00:00  |  Presenting Author(s): Ajeet Gajra

      • Abstract

      Loading...

    • +

      P09.22 - Curative Intent Treatment for Small Cell Lung Cancer in England

      00:00 - 00:00  |  Presenting Author(s): Susan Harden

      • Abstract

      Loading...

    • +

      P09.23 - Real-World Treatment Patterns and Outcomes in Patients with NSCLC in England (ROSANNE): A Retrospective Study

      00:00 - 00:00  |  Presenting Author(s): Alastair Greystoke

      • Abstract

      Loading...

    • +

      P09.24 - Real-World Data in Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors in a Latin American Institution

      00:00 - 00:00  |  Presenting Author(s): Tania Paytan

      • Abstract

      Loading...

    • +

      P09.25 - Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Monica Peravali

      • Abstract

      Loading...

    • +

      P09.26 - Cause of Death in Patients with Squamous Cell Lung Cancer (SCC) Treated with Surgery

      00:00 - 00:00  |  Presenting Author(s): Nirav Nicholas Antao

      • Abstract

      Loading...

    • +

      P09.27 - Descriptive Review of Breast Cancer Patients With Subsequent Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Mah Noor

      • Abstract

      Loading...

    • +

      P09.28 - Access to Intermediate and Intensive Care for Patients With Lung Cancer During the COVID-19 Period

      00:00 - 00:00  |  Presenting Author(s): Teresa Gorría

      • Abstract

      Loading...

    • +

      P09.29 - Immune-Related Adverse Events and their Association with Effectiveness of PD-1/PD-L1 Inhibitors in NSCLC: A Real-World Study from China

      00:00 - 00:00  |  Presenting Author(s): Xiaoling Chen

      • Abstract

      Loading...

    • +

      P09.30 - A Clinical and Molecular Portrait of a Younger Population with Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Sophie Stock-Martineau

      • Abstract

      Loading...

    • +

      P09.31 - Adherence to Treatment Recommendations from Multidisciplinary Tumor Boards

      00:00 - 00:00  |  Presenting Author(s): Julia Roeper

      • Abstract

      Loading...

    • +

      P09.32 - Is the New Patient Respiratory Appointment an Appropriate Time to Refer Patients With Likely Lung Cancer for Prehabilitation?

      00:00 - 00:00  |  Presenting Author(s): Lauren Glanville

      • Abstract

      Loading...

    • +

      P09.33 - Outcomes of Patients with Lung Cancer Tested for COVID-19 in a Chicago Hospital System (LungCOVID-Chicago)

      00:00 - 00:00  |  Presenting Author(s): Ryan Nguyen

      • Abstract

      Loading...

    • +

      P09.34 - Curating Online Journal Clubs to Advance Global Oncology Lung Cancer Care

      00:00 - 00:00  |  Presenting Author(s): Ian J Pereira

      • Abstract

      Loading...

    • +

      P09.35 - COVID-19 in Patients with Lung Cancer – Experience from a Thoracic Oncology Center

      00:00 - 00:00  |  Presenting Author(s): David Coelho

      • Abstract

      Loading...

    • +

      P09.36 - Impact of Medicaid Enrollment on Mortality in Elderly Dual-Eligible Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Meera Ragavan

      • Abstract

      Loading...

    • +

      P09.37 - Pragmatic Trial Design to Compare Surveillance Strategies for Patients with Small Pulmonary Nodules: The Watch the Spot Trial

      00:00 - 00:00  |  Presenting Author(s): Beth Creekmur

      • Abstract

      Loading...

    • +

      P09.38 - 2020: COVID19 Impact in Lung Cancer Resection in a University Hospital of Brazil

      00:00 - 00:00  |  Presenting Author(s): Paulo Alfredo Casanova Schulze

      • Abstract

      Loading...

    • +

      P09.39 - PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel – Analysis of Real-World Data.

      00:00 - 00:00  |  Presenting Author(s): Sarah Sharman Moser

      • Abstract

      Loading...

    • +

      P09.40 - Treatment Pattern in Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC) in South China

      00:00 - 00:00  |  Presenting Author(s): Joseph Siu-Kie Au

      • Abstract

      Loading...

    • +

      P09.41 - Body Mass Index (BMI) Is Associated With Overall Survival in Patients With Metastatic Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Maria Fernanda Medeiros

      • Abstract

      Loading...

    • +

      P09.42 - Second-Line Immunotherapy Treatment Patterns in Non-Small Cell Lung Cancer in Portugal: An I-O Optimise Cohort Study

      00:00 - 00:00  |  Presenting Author(s): Marta Soares

      • Abstract

      Loading...

    • +

      P09.43 - Familial History of Cancer and Overall Survival in NSCLC Patients.

      00:00 - 00:00  |  Presenting Author(s): Débora Maciel Santana

      • Abstract

      Loading...

    • +

      P09.44 - Outcomes of Covid-19 Infection in Lung Cancer Patients: Experience from a Large Tertiary Care Cancer Center

      00:00 - 00:00  |  Presenting Author(s): Kiran Munawar

      • Abstract

      Loading...

    • +

      P09.45 - Ten Year Report of Lung Cancer in Never Smokers from Southeast of Brasil

      00:00 - 00:00  |  Presenting Author(s): sabina bandeira Aleixo

      • Abstract

      Loading...

    • +

      P09.46 - Non-Small Cell Lung Cancer Comorbid with Tuberculosis is Associated with Better Prognosis

      00:00 - 00:00  |  Presenting Author(s): Ho-Sheng Lee

      • Abstract

      Loading...

    • +

      P09.47 - Implementation of Lung Cancer Multidisciplinary Care: A Rapid Review of Evidence-Practice Gaps

      00:00 - 00:00  |  Presenting Author(s): Nicole Rankin

      • Abstract

      Loading...

    • +

      P09.48 - Experience and Outcome of COVID-19-Positive Lung Cancer Patients from a Eastern Indian Hospital

      00:00 - 00:00  |  Presenting Author(s): Satya Mantha Padmaja

      • Abstract

      Loading...

    • +

      P09.49 - Experience with Immunotherapy Treatment in Fundación Santa Fe Bogotá: Real World Data in Metastatic Non-Small Cell Lung Cancer Patients.

      00:00 - 00:00  |  Presenting Author(s): Aylen Vanessa Ospina Serrano

      • Abstract

      Loading...

    • +

      P09.50 - Lung Cancer Hospitalization Burden. Generating Knowledge from Administrative Data to Optimize Management.

      00:00 - 00:00  |  Presenting Author(s): Virginia Calvo

      • Abstract

      Loading...

    • +

      P09.51 - Lung Adenocarcinoma in Morocco

      00:00 - 00:00  |  Presenting Author(s): Ouassima Erefai

      • Abstract

      Loading...

    • +

      P09.52 - Explore-LC: Uniting Existing Real-World Date Sources to Create a Novel Asia-Pacific Wide Research Platform for Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): David Horsburgh

      • Abstract

      Loading...

    • +

      P09.53 - Comparative Effectiveness of Crizotinib versus Entrectinib in ROS1+ Non-Small Cell Lung Cancer (NSCLC) using Clinical Trial and Real-World Data

      00:00 - 00:00  |  Presenting Author(s): Laura Iadeluca

      • Abstract

      Loading...

    • +

      P09.54 - Pneumonitis Following Durvalumab: A Real-World Analysis in Patients with Lung Cancer and Other Tumor Types

      00:00 - 00:00  |  Presenting Author(s): Ajeet Gajra

      • Abstract

      Loading...

    • +

      P09.55 - A Platform to Prospectively Link Real-World Clinico-Genomic, Imaging, and Outcomes Data for Patients With Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Guneet Walia

      • Abstract

      Loading...

    • +

      P09.56 - Real-World Outcomes Among Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Lauren Bartolome

      • Abstract

      Loading...

    • +

      P09.57 - Estimating the Total US Incidence of Advanced/Metastatic Non-Small Cell Lung (NSCLC) Including Recurrent Disease

      00:00 - 00:00  |  Presenting Author(s): Shervin J Shirvani

      • Abstract

      Loading...

    • +

      P09.58 - Replication of Overall Survival in Chemotherapy Arms of 1L NSCLC Trials using Real-World Data External Controls

      00:00 - 00:00  |  Presenting Author(s): Navdeep Pal

      • Abstract

      Loading...

    • +

      P09.59 - Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece

      00:00 - 00:00  |  Presenting Author(s): KONSTANTINOS Syrigos

      • Abstract

      Loading...

    • +

      P09.60 - Using Patient-Level Data from Electronic Health Records to Replicate PFS Outcomes for Four 1L NSCLC Trials

      00:00 - 00:00  |  Presenting Author(s): Michael T Bretscher

      • Abstract

      Loading...

    • +

      P09.61 - Epidemiological and Clinical Burden of EGFR Exon 20 Insertion in Advanced NSCLC: Results of a Systematic Literature Review

      00:00 - 00:00  |  Presenting Author(s): Tracy Li

      • Abstract

      Loading...

  • +

    P10 - Health Services Research/Health Economics - Health Economics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P10.01 - Bias Comparison in Studies Funded by Industry and by Other Sources: An Analysis of Prospective Studies of the Last Five Years

      00:00 - 00:00  |  Presenting Author(s): Silvio Matsas

      • Abstract

      Loading...

    • +

      P10.02 - A comparison Between the Cost of Lung Cancer Treatment and how much is made Available by Brazilian Government 

      00:00 - 00:00  |  Presenting Author(s): Marina Kelner Silveira

      • Abstract

      Loading...

    • +

      P10.03 - Health Insurance Coverage and Racial Disparities in Early-Stage Detection and Treatment of Lung Cancer: A Causal Mediation Analysis

      00:00 - 00:00  |  Presenting Author(s): Zhe Pan

      • Abstract

      Loading...

    • +

      P10.04 - A Budget Impact Analysis for Treatment with Ramucirumab Plus Erlotinib in Metastatic EGFR-Mutated NSCLC in the US

      00:00 - 00:00  |  Presenting Author(s): Katherine B. Winfree

      • Abstract

      Loading...

  • +

    P11 - Health Services Research/Health Economics - Quality of Life

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P11.01 - Exploring Patient Reported Quality of Life in Lung Cancer Patients: A Qualitative Study

      00:00 - 00:00  |  Presenting Author(s): Elena Jensen-Marini

      • Abstract

      Loading...

    • +

      P11.02 - Patient Reported Outcome Measures (PROM) after Thoracic Surgery: A Pilot Study

      00:00 - 00:00  |  Presenting Author(s): Jitian Zhang

      • Abstract

      Loading...

    • +

      P11.03 - Importance of Capturing the Patient Experience of Overall Symptoms and HRQoL Impact in Patients With ALK+ NSCLC

      00:00 - 00:00  |  Presenting Author(s): Yanyan Zhu

      • Abstract

      Loading...

  • +

    P12 - Health Services Research/Health Economics - Health Policy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P12.01 - Pilot Training Program, Redesign of the Attention System and Time Reduction on Lung Cancer Patients in a Mexican Hospital 

      00:00 - 00:00  |  Presenting Author(s): Saul Campos-Gomez

      • Abstract

      Loading...

    • +

      P12.02 - Implementation of a Timeliness-of-care Pathway System for Lung Cancer Patients in a Private Outpatient Oncology Service.

      00:00 - 00:00  |  Presenting Author(s): Iuri Amorim Santana

      • Abstract

      Loading...

    • +

      P12.03 - Public Versus Private Care Patients Treated in the Same Hospital. Are the Patients the Same?

      00:00 - 00:00  |  Presenting Author(s): Maria Teresa Ruiz Tsukazan

      • Abstract

      Loading...

    • +

      P12.04 - Access of Lung Cancer to High Technology Radiation Therapy in Brazil

      00:00 - 00:00  |  Presenting Author(s): LILIAN Faroni

      • Abstract

      Loading...

    • +

      P12.05 - Current State and Challenges of Lung Cancer Treatment in Georgia

      00:00 - 00:00  |  Presenting Author(s): Elene Mariamidze

      • Abstract

      Loading...

  • +

    P13 - Health Services Research/Health Economics - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P13.01 - Analysis of the Effect of Personalized Nursing in Patients Undergoing Thoracoscopic Surgery for NSCLC

      00:00 - 00:00  |  Presenting Author(s): Yuanyong Wang

      • Abstract

      Loading...

    • +

      P13.02 - Role of Management Checklist in the Prevention and Control of NCP in Oncology Ward

      00:00 - 00:00  |  Presenting Author(s): Li Li

      • Abstract

      Loading...

    • +

      P13.03 - The Role of Nurse Practitioners Within Thoracic Radiation Oncology and the Benefit to Patients, Physicians and the Healthcare System

      00:00 - 00:00  |  Presenting Author(s): Ulrike Gorgens

      • Abstract

      Loading...

    • +

      P13.04 - Should We Offer Germline Testing to All Patients With Lung Cancer? An Ethical Point of View.

      00:00 - 00:00  |  Presenting Author(s): Guillermo Pacheco-Cuellar

      • Abstract

      Loading...

    • +

      P13.05 - Real-World Treatment Patterns and Sequencing of Immunotherapy and Chemotherapy Based on PD-L1 TPS in European Patients With mNSCLC

      00:00 - 00:00  |  Presenting Author(s): Megan N Gower

      • Abstract

      Loading...

  • +

    P14 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Immuno-Biology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      P14.01 - Impact of Stimulator of Interferon Genes (STING) Signaling on the Tumor Immune Microenvironment in Lung Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): Jiewei Liu

      • Abstract

      Loading...

    • +

      P14.02 - Expression and Significance of Indoleamine 2,3 Dioxygenase on Tumor Cell and Tumor Stroma Compartments of Lung Squamous Cell Carcinoma

      00:00 - 00:00  |  Presenting Author(s): Wei Wang

      • Abstract

      Loading...

    • +

      P14.03 - Increased Tumor-Associated LAG-3+ Lymphocytes Correlate with Aggressive Tumor Behavior and Worse Prognosis in Lung Adenocarcinoma

      00:00 - 00:00  |  Presenting Author(s): Dan Shepherd

      • Abstract

      Loading...

    • +

      P14.04 - cfRNA from Liquid Biopsies Is More Abundant Than cfDNA, Informs Treatment Outcome and Is Concordant with Tissue

      00:00 - 00:00  |  Presenting Author(s): Luis E. Raez

      • Abstract

      Loading...

    • +

      P14.05 - The Relationship Between Genomic Alterations and the Efficacy of Immune Check Point Inhibitor for KRAS Mutated Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Naoki Furuya

      • Abstract

      Loading...

    • +

      P14.06 - Dysregulation of m6a Reader IGF2BP1 in Lung Adenocarcinoma Affects the Immune Microenvironment and Indicates a Poor Recovery

      00:00 - 00:00  |  Presenting Author(s): Xuequan Wang

      • Abstract

      Loading...

    • +

      P14.07 - Clinically Predictive Value of Plasma Cell-Free DNA in Lung Cancer Immunotherapy

      00:00 - 00:00  |  Presenting Author(s): Lin Li

      • Abstract

      Loading...

    • +

      P14.08 - Baseline Nlr and Plr Could Predict Clinical Outcomes in Patients With NSCLC Treated With ICIs

      00:00 - 00:00  |  Presenting Author(s): anwen Xiong

      • Abstract

      Loading...

    • +

      P14.09 - Early Expansion of M-MDSCs and High Plasma TSLP levels as Predictors of Primary Resistance to PD1 Inhibitors in Metastatic NSCLC

      00:00 - 00:00  |  Presenting Author(s): Sally Chui Mei Lau

      • Abstract

      Loading...

    • +

      P14.10 - Efficacy of Anti-PD-1/PD-L1 Monoclonal Antibody Treatment of Advanced NSCLC on Density and Distribution of Tumor Infiltrating T Cells

      00:00 - 00:00  |  Presenting Author(s): Yuanyong Wang

      • Abstract

      Loading...

    • +

      P14.11 - Optimal Combination of Biomarkers to Improve the Predictive Value of Immunotherapeutic Response in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Soohyeon Kwon

      • Abstract

      Loading...

    • +

      P14.12 - MET Amplification and Immune Checkpoint Inhibitor Efficacy in NSCLC

      00:00 - 00:00  |  Presenting Author(s): shan Su

      • Abstract

      Loading...

    • +

      P14.13 - Notch Family Gene Mutations Predict Clinical Benefit from Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Huaqiang Zhou

      • Abstract

      Loading...

    • +

      P14.14 - PTPRD: A Positive Predictive Biomarker for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jiayi Shen

      • Abstract

      Loading...

    • +

      P14.15 - Circulating Tumor DNA Predict the Response and Survival after Tislelizumab Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma

      00:00 - 00:00  |  Presenting Author(s): qiong He

      • Abstract

      Loading...

    • +

      P14.16 - The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors

      00:00 - 00:00  |  Presenting Author(s): Jianguo Zhou

      • Abstract

      Loading...

    • +

      P14.17 - Low BMI is Associated with Inferior Overall Survival in HIV Patients with Advanced NSCLC Undergoing Immunotherapy

      00:00 - 00:00  |  Presenting Author(s): Emily Lin

      • Abstract

      Loading...

    • +

      P14.18 - Expression and Clinical Significance of CMTM6 in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Sisi He

      • Abstract

      Loading...

    • +

      P14.19 - CD8α-Enhanced NY-ESO-1-Specific TCR T Cells (GSK3901961) in HLA-A*02 Patients with NSCLC: Master Protocol Substudy 1

      00:00 - 00:00  |  Presenting Author(s): Mehmet Altan

      • Abstract

      Loading...

    • +

      P14.20 - Multi-Spectral Imaging of Lung Adenocarcinoma Reveals Importance of Cancer Specific HLA-DR on the TME and Clinical Outcome

      00:00 - 00:00  |  Presenting Author(s): Erin L Schenk

      • Abstract

      Loading...

    • +

      P14.21 - Baseline Derived Neutrophil-to-Lymphocyte Ratio (dNLR) and Clinical Outcomes to First-Line Pembrolizumab in NSCLC with High PD-L1 (≥50%) 

      00:00 - 00:00  |  Presenting Author(s): Joao Victor M. Alessi

      • Abstract

      Loading...

    • +

      P14.22 - Radiotherapy With Sequential αnti-PD-1 mAb Is Better in Enhancing the Abscopal Effect by Promoting the Inflammatory Tumor Microenvironment

      00:00 - 00:00  |  Presenting Author(s): Xiaoxia Zhu

      • Abstract

      Loading...

    • +

      P14.23 - Different in Situ Immune Pattern Between Primary Tumor and Metastatic Lymph Node in NSCLC: Potential Impact on Neoadjuvant Immunotherapy

      00:00 - 00:00  |  Presenting Author(s): Ze-Rui Zhao

      • Abstract

      Loading...

    • +

      P14.24 - Evolution of TCR Clonality during Chemoradiation and Durvalumab as Predictors of Survival in Stage 3 NSCLC

      00:00 - 00:00  |  Presenting Author(s): Sally Chui Mei Lau

      • Abstract

      Loading...

    • +

      P14.25 - Immune Cell Profiling of Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Antibodies

      00:00 - 00:00  |  Presenting Author(s): Kyung Hwan Kim

      • Abstract

      Loading...

    • +

      P14.26 - Diminished Efficacy of PD-(L)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma is Impacted by KRAS Mutation Status

      00:00 - 00:00  |  Presenting Author(s): Biagio Ricciuti

      • Abstract

      Loading...

    • +

      P14.27 - Pathogenic Genomic Alterations of CDKN2A Predict Immunotherapy Resistance in NSCLC

      00:00 - 00:00  |  Presenting Author(s): Stanley Gutiontov

      • Abstract

      Loading...

    • +

      P14.28 - Association Between the Type of First-Line Chemotherapy and Outcome of Second-Line Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Mihyun Kim

      • Abstract

      Loading...

    • +

      P14.29 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study

      00:00 - 00:00  |  Presenting Author(s): Baohui Han

      • Abstract

      Loading...

    • +

      P14.30 - EDIC and Circulating Lymphocytes Decreasing Related with Thymus and Thoracic Duct Irradiation in Primary Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): jinliang Zhang

      • Abstract

      Loading...

    • +

      P14.31 - Assessment of TMB in Lung Adenosquamous Carcinomas

      00:00 - 00:00  |  Presenting Author(s): Xiaoqun Ye

      • Abstract

      Loading...

    • +

      P14.32 - Predictive Value of Neutrophil-Lymphocyte Ratio on the Outcome of Patients with Advance NSCLC Treated with PD-1 Inhibition and Radiotherapy

      00:00 - 00:00  |  Presenting Author(s): Fen Wang

      • Abstract

      Loading...

    • +

      P14.33 - Soluble PD-L1 as Biomarker of Benefit from Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Carlo Genova

      • Abstract

      Loading...

  • +

    P15 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Phase I)

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      P15.01 - AMG 757, a Half-Life Extended Bispecific T-Cell Engager (HLE BiTE® Immune Therapy) Targeting DLL3, for the Treatment of Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Keegan Cooke

      • Abstract

      Loading...

    • +

      P15.02 - Phase Ib Study to Evaluate the Safety and Efficacy of Osimertinib in Combination with Ipilimumab in EGFR Mutated NSCLC

      00:00 - 00:00  |  Presenting Author(s): Sonam Puri

      • Abstract

      Loading...

    • +

      P15.03 - A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC

      00:00 - 00:00  |  Presenting Author(s): Koichi Goto

      • Abstract

      Loading...

    • +

      P15.04 - A Phase I/IB Trial of Pembrolizumab and Trametinib Focused on Advanced KRAS Mutant Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jonathan Riess

      • Abstract

      Loading...

    • +

      P15.05 - Phase I of Sintilimab in Combination with Low Dose Radiation After SBRT in Treatment Naive PD-L1 Positive Stage IV Non-Small Cell Lung Cancer 

      00:00 - 00:00  |  Presenting Author(s): jianxin Xue

      • Abstract

      Loading...

    • +

      P15.06 - Safety of BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody Plus Platinum/Etoposide in Untreated Extensive-Stage SCLC

      00:00 - 00:00  |  Presenting Author(s): Luis G. Paz-Ares

      • Abstract

      Loading...

    • +

      P15.07 - Safety and Efficacy Profile of TQB-2450 Alone/with Anlotinib in Previously-Treated Advanced NSCLC: A Phase IB Single-Arm Trial      

      00:00 - 00:00  |  Presenting Author(s): Baohui Han

      • Abstract

      Loading...

    • +

      P15.08 - Phase I Trial of in situ Vaccination With Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined With Pembrolizumab for Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Aaron Lisberg

      • Abstract

      Loading...

    • +

      P15.09 - A Promising Result of Two Therapeutic Peptides Combined with Chemotherapy in the Treatment of Advanced NSCLC.

      00:00 - 00:00  |  Presenting Author(s): Jiangnan Feng

      • Abstract

      Loading...

  • +

    P16 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Translational)

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      P16.01 - The Effect of Different Dose and Sites of Irradiation on Lymphocyte Subsets in Peripheral Blood of Patients With Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Xiaoxia Zhu

      • Abstract

      Loading...

    • +

      P16.02 - Impact of Number and Location of Metastatic Sites on Survival in Stage IV ICI-Treated NSCLC

      00:00 - 00:00  |  Presenting Author(s): Amanda Jane Williams Gibson

      • Abstract

      Loading...

    • +

      P16.03 - Early Mortality Associated Factors With Immune Checkpoint Inhibition in Real-World Canadian NSCLC Patients

      00:00 - 00:00  |  Presenting Author(s): Amanda Jane Williams Gibson

      • Abstract

      Loading...

    • +

      P16.04 - CDK4/6 Inhibitors Reverse Resistance to Anti-PD-1 Therapy in Lung Adenocarcinoma with LKB1 Deficiency Through pRB-ICAM1 Dependent Signaling

      00:00 - 00:00  |  Presenting Author(s): Zhong-Yi Dong

      • Abstract

      Loading...

    • +

      P16.05 - Exploratory Study of Sintilimab Intrapleural Therapy for NSCLC-Mediated Malignant Pleural Effusion

      00:00 - 00:00  |  Presenting Author(s): Tangfeng Lv

      • Abstract

      Loading...

    • +

      P16.06 - Exploration of Efficacy and irAEs of Pembrolizumab Plus Chemotherapy for Advanced NSCLC as 1st Line Treatment in Real World

      00:00 - 00:00  |  Presenting Author(s): Teng Li

      • Abstract

      Loading...

    • +

      P16.07 - Immuno-Modulatory Effects of Ceralasertib in Combination with Durvalumab in NSCLC with Progression on Anti-PD(L)1 Treatment (HUDSON) 

      00:00 - 00:00  |  Presenting Author(s): Benjamin Besse

      • Abstract

      Loading...

  • +

    P17 - Locoregional and Oligometastatic Disease - Biomarkers

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • +

      P17.01 - Adaptive Elastic-Net Nomogram Predicting Disease-Free Survival in Resected Stage IIIA (N2) Non–Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Chenchen Zhang

      • Abstract

      Loading...

    • +

      P17.02 - Durvalumab After chemoRadioTherapy (DART) for NSCLC Patients – a Phase II Translational and Biomarker Study

      00:00 - 00:00  |  Presenting Author(s): Vilde Drageset Haakensen

      • Abstract

      Loading...

    • +

      P17.03 - Lung Adenocarcinoma with Lymph Node Metastasis: Is Ground Glass Opacity Component a Prognostic Factor?

      00:00 - 00:00  |  Presenting Author(s): Xiangyi Ma

      • Abstract

      Loading...

  • +

    P18 - Locoregional and Oligometastatic Disease - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • +

      P18.01 - Prognostic Value of the LIPI in Patients with LA-NSCLC Receiving Definitive RT: A Retrospective Study of 1079 Patients

      00:00 - 00:00  |  Presenting Author(s): Wenji Xue

      • Abstract

      Loading...

    • +

      P18.02 - Factors Influencing Multi-Disciplinary Tumor Board Recommendations in Stage III Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Merle Ilona Ronden

      • Abstract

      Loading...

    • +

      P18.03 - Randomized Trial With BIALOE to Prevent Esophagitis in Lung Cancer Patients Treated With Concurrent Radical Chemoradiotherapy

      00:00 - 00:00  |  Presenting Author(s): Francesc Casas

      • Abstract

      Loading...

    • +

      P18.04 - Individualized Fraction Regimen of SBRT Patients with Non-small Cell Lung Cancer Based on Uncomplicated and Cancer-free Control Probability

      00:00 - 00:00  |  Presenting Author(s): AiHui Feng

      • Abstract

      Loading...

    • +

      P18.05 - Immunotherapy Beyond First-Line in NSCLC, Still An Option.

      00:00 - 00:00  |  Presenting Author(s): Andrea Modrego

      • Abstract

      Loading...

    • +

      P18.06 - Retrospective Epidemiological Study of Locally Advanced Non-Small Cell Lung Cancer Patients in Brazil – RELANCE (LACOG 0118)

      00:00 - 00:00  |  Presenting Author(s): Vladmir Claudio Cordeiro De Lima

      • Abstract

      Loading...